Patents Represented by Attorney Ruby Hope

Find this attorney in the Justia Lawyer Directory

  • Solvents useful in the preparation of polymers containing hydrophilic and hydrophobic monomers
    Patent number: 7112652
    Abstract: This invention relates to solvents which may be used to extract polymers that are made of hydrophilic and hydrophobic monomers.
    Type: Grant
    Filed: January 12, 2004
    Date of Patent: September 26, 2006
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: James D. Ford, Azaam Alli, Ture Kindt-Larsen
  • Method and system for inspecting optical devices
    Patent number: 6882411
    Abstract: The invention includes methods and apparatuses for inspecting optical devices, particularly contact lenses.
    Type: Grant
    Filed: February 21, 2003
    Date of Patent: April 19, 2005
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Anthony J. Dispenza, James Ebel, Kevin Giles, Michael F. Widman
  • Heterocycles useful in the treatment of benign prostatic hyperplasia
    Patent number: 6384035
    Abstract: This invention relates a to a series of heterocyclic substituted piperazines of Formula I pharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the invention selectively inhibit binding to the &agr;-1a adrenergic receptor, a receptor which has been implicated in benign prostatic hyperplasia. As such the compounds are potentially useful in the treatment of this disease.
    Type: Grant
    Filed: October 9, 1998
    Date of Patent: May 7, 2002
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Richard H. Hutchings, Haripada Khatuya, Gee-Hong Kuo, Xiaobing Li, William V. Murray, Catherine Prouty, Frank Villani, Nelson C. F. Yim, Cynthia Maryanoff
  • Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
    Patent number: 6362338
    Abstract: This invention relates to a series of substituted piperazines of Formula II, as well as enantiomers thereof These compounds are useful in the manufacture of pharmaceutical compositions.
    Type: Grant
    Filed: January 21, 2000
    Date of Patent: March 26, 2002
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Gee-Hong Kuo, William V. Murray, Catherine P. Prouty
  • Clear, colorless soap bar with superior mildness, lathering and discoloration resistance
    Patent number: 5962382
    Abstract: The present invention relates to a clear colorless soap bar with superior mildness, lathering and discoloration resistance. The clear colorless soap consists of a blend of C12-C18 fatty acids neutralized with sodium hydroxide (NaOH) and triethanolamine (TEA). Excess TEA acts as a co-solvent and is responsible for clarity of the soap bar. The bar also contains a branched chain acid such as isostearic acid to break up crystallinity and add to product clarity. Low color and color stability are obtained by removing unsaturated fatty acids, and by the use of antioxidants (BHT and Vitamin E). Low levels of C6 to C10 fatty acids provide exceptional mildness.
    Type: Grant
    Filed: October 22, 1997
    Date of Patent: October 5, 1999
    Assignee: Johnson & Johnson Consumer Products, Inc.
    Inventor: Danilo L. Lambino